Oxyniff Mini Nasal Spray contains Oxymetazoline 0.01% w/v, a fast-acting nasal decongestant used for nasal congestion, sinus blockage, and allergy-related nasal obstruction.
Oxymetazoline works by constricting blood vessels in the nasal passages, providing quick relief from stuffiness and improved breathing. Its formulation ensures safe and effective repeated use within recommended dosage.
Clinically, Oxyniff Mini Nasal Spray is widely used in ENT clinics, pharmacies, and home care, offering rapid symptomatic relief and high patient satisfaction.
From a business perspective, Oxyniff Mini Nasal Spray strengthens the nasal care segment, delivering consistent prescription demand, repeat sales, and profitable PCD pharma franchise opportunities at a best price for franchise partners.
Common side effects may include mild stinging, burning, or dryness in the nasal passages. Rarely, prolonged use may lead to rebound congestion, headache, dizziness, or elevated blood pressure.
Oxyniff Mini Nasal Spray is indicated for the temporary relief of nasal congestion associated with allergic rhinitis, common cold, sinusitis, or upper respiratory tract infections. It helps open nasal passages and improve breathing.
Use Oxyniff Mini Nasal Spray strictly as directed by a healthcare professional. Do not exceed the recommended dosage or duration of use (usually not more than 3–5 days) to avoid rebound congestion. Discontinue and consult a doctor if severe irritation, persistent congestion, or unusual symptoms occur.
Store in a cool, dry place below 25°C. Protect from direct sunlight, keep the bottle tightly closed, and out of reach of children. Do not use beyond the expiry date.